Call for Papers: Inaugural Volume (Vol. 1, 2026)

The Journal of Artificial Intelligence in Healthcare & Life Sciences (JAIHL) invites original, high-quality scholarly submissions for its inaugural volume. JAIHL serves as an international, open-access forum dedicated to advancing the application, methodology, and ethical deployment of artificial intelligence across clinical medicine, biomedical research, and life science domains.

We publish peer-reviewed research that bridges computational innovation with real-world clinical and translational relevance.

1. Scope of the Journal

JAIHL welcomes original contributions across, but not limited to, the following core tracks:

  • Medical AI & Diagnostics: Deep learning for medical imaging, radiology, computer vision, digital pathology, and early disease detection.
  • Drug Discovery & Genomics: Machine learning in molecular design, target identification, genomics, proteomics, and systems biology.
  • Clinical Decision Support Systems: AI-driven diagnostic tools, risk stratification models, precision oncology, and clinical workflow optimization.
  • Healthcare Data Science & NLP: Natural language processing for electronic health records (EHRs), biomedical text mining, and clinical knowledge graphs.
  • Public & Global Health AI: Predictive epidemiology, automated disease surveillance, population health modeling, and health equity analytics.
  • AI Ethics & Governance: Studies addressing algorithmic fairness, explainable AI (XAI), regulatory compliance, and translational implementation barriers.

2. Accepted Article Types

To support diverse scientific contributions, JAIHL accepts the following manuscript formats:

  • Original Research Articles (Full-length empirical investigations)
  • Review Articles / Systematic Reviews & Meta-Analyses
  • Methodological & Technical Papers (Introducing new architectures, algorithms, or pipelines)
  • Short Communications (High-impact preliminary findings or brief reports)
  • Case Studies (Demonstrating novel, field-tested AI-driven clinical insights)

3. Why Publish in JAIHL?

  • Rapid, High-Quality Review: Our optimized, double-anonymized peer-review workflow delivers a first-round decision within 3–4 weeks.
  • Global Visibility: Fully open-access publishing model under the CC BY 4.0 license, ensuring immediate, unrestricted global dissemination.
  • Subsidized Model: Standard APC (€550) applies exclusively to funded research; comprehensive fee waivers are available for independent or unsupported researchers to ensure financial status never limits publication.

4. Submission & Registration Guidelines

  • Manuscript Preparation: Authors must format their work strictly in accordance with JAIHL's Author Guidelines prior to submission. Full disclosures regarding publication ethics, plagiarism screening via iThenticate, and the use of Generative AI tools are mandatory.
  • Online Submission: Manuscripts must be submitted electronically through our secure OJS portal.
  • How to Submit:
    1. Click on Register to create an account using a valid institutional or professional email address.
    2. Log into the dashboard and follow the intuitive 5-step wizard to upload your manuscript files and complete the metadata profile.
    3. Track your article’s peer-review progress directly from your author portal in real time.

5. Important Deadlines & Launch Timeline

  • Inaugural Issue Submission Window: Open Now
  • Target Publication Window: Accepted papers are published online immediately in our continuous production workflow for Volume 1.